Close this search box.

Clinical, Operational, and Financial Impact of CapsoCam Plus® on Display at DDW 2024

CapsoVision will demonstrate the clinical, operational, and financial impact of CapsoCam Plus® at DDW 2024, the world’s premier gathering of gastroenterology clinicians, researchers and industry professionals. Join CapsoVision at booth 1628 at DDW 2004 as the field’s brightest minds unite in Washington, D.C., and online, ready to share in the latest discoveries shaping digestive health.

CapsoVision Offers Capsule Endoscopy Reading Service

The CapsoCam Plus® Reading Service maximizes your productivity by expediting your reports. All readers are US-based, board-certified gastroenterologists with extensive experience in the interpretation of CapsoCam Plus capsule endoscopy images.

CapsoVision Achieves ISO 27001:2013 Certification For Information Security Management System

SARATOGA, Calif., Dec. 4, 2020 /PRNewswire/ — CapsoVision, Inc., an innovator in the gastroenterology diagnostics market and manufacturer of the CapsoCam Plus® capsule endoscope, today announced that it has achieved the International Standard Organization (ISO) 27001 security certification. The scope of the certification includes CapsoVision’s headquarter and the company’s CapsoCloud® software. CapsoVision is ISO/IEC 27001:2013 certified with TÜV Rheinland […]

CapsoVision Inc. Announces FDA Enforcement Discretion for At-Home Capsule Endoscopy Administration of CapsoCam Plus during COVID-19

SARATOGA, Calif., Sept. 23, 2020 /PRNewswire/ — CapsoVision, an innovator in the gastroenterology diagnostics market, today announced that the U.S Food & Drug Administration (FDA) will apply enforcement discretion which allows at-home administration of the CapsoCam Plus® small bowel capsule endoscope during the COVID-19 pandemic for patients who are determined eligible for at-home administration. Read more